Royce & Associates LP
- SEC CIK
- 0000906304
- Latest filing
- Aug 14, 2026
XFOR holding history
X4 Pharmaceuticals, Inc in every 13F filed by Royce & Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XFOR overviewAll 13F holders of XFORFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −342,363−100.0% | Sold out | Holders |
| Q1 2024 | 342,363 | $475.9K | <0.1% | −46,000−11.8% | Reduced | Holders |
| Q4 2023 | 388,363 | $325.6K | <0.1% | +269,357+226.3% | Added | Holders |
| Q3 2023 | 119,006 | $129.7K | <0.1% | +65,516+122.5% | Added | Holders |
| Q2 2023 | 53,490 | $103.8K | <0.1% | +53,490 | New | Holders |